CDK8
Basic information
Region (hg38): 13:26254104-26420982
Links
Phenotypes
GenCC
Source:
- intellectual developmental disorder with hypotonia and behavioral abnormalities (Moderate), mode of inheritance: AD
- intellectual developmental disorder with hypotonia and behavioral abnormalities (Strong), mode of inheritance: AD
- intellectual developmental disorder with hypotonia and behavioral abnormalities (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Intellectual developmental disorder with hypotonia and behavioral abnormalities | AD | Cardiovascular | Individuals have been described as affected with a range of cardiovascular anomalies, including potentially occult anomalies requiring interventions, and awareness may allow early diagnosis and management | Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic | 30905399 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (31 variants)
- Intellectual_developmental_disorder_with_hypotonia_and_behavioral_abnormalities (30 variants)
- Inborn_genetic_diseases (23 variants)
- CDK8-related_disorder (7 variants)
- Common_atrium (1 variants)
- Ventriculomegaly (1 variants)
- Ebstein_anomaly (1 variants)
- Stillbirth (1 variants)
- Intellectual_disability (1 variants)
- Abnormal_facial_shape (1 variants)
- Congenital_diaphragmatic_hernia (1 variants)
- Heart,_malformation_of (1 variants)
- Complex_neurodevelopmental_disorder_with_or_without_congenital_anomalies (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDK8 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001260.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | |||||
| missense | 57 | 77 | ||||
| nonsense | 1 | |||||
| start loss | 0 | |||||
| frameshift | 2 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 10 | 8 | 59 | 7 | 0 |
Highest pathogenic variant AF is 0.000003103306
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CDK8 | protein_coding | protein_coding | ENST00000381527 | 13 | 151100 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.410 | 0.590 | 125740 | 0 | 8 | 125748 | 0.0000318 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 3.68 | 87 | 251 | 0.346 | 0.0000125 | 3048 |
| Missense in Polyphen | 11 | 64.52 | 0.17049 | 769 | ||
| Synonymous | 0.590 | 79 | 86.0 | 0.919 | 0.00000433 | 833 |
| Loss of Function | 4.04 | 7 | 31.4 | 0.223 | 0.00000182 | 354 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000582 | 0.0000582 |
| Ashkenazi Jewish | 0.0000992 | 0.0000992 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000356 | 0.0000352 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000333 | 0.0000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the Mediator complex, a coactivator involved in regulated gene transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. Phosphorylates the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAp II), which may inhibit the formation of a transcription initiation complex. Phosphorylates CCNH leading to down-regulation of the TFIIH complex and transcriptional repression. Recruited through interaction with MAML1 to hyperphosphorylate the intracellular domain of NOTCH, leading to its degradation. {ECO:0000269|PubMed:10993082, ECO:0000269|PubMed:15546612}.;
- Pathway
- Sterol Regulatory Element-Binding Proteins (SREBP) signalling;H19 action Rb-E2F1 signaling and CDK-β-catenin activity;Developmental Biology;Disease;Signal Transduction;Gene expression (Transcription);estrogen responsive protein efp controls cell cycle and breast tumors growth;Generic Transcription Pathway;Hedgehog;RNA Polymerase II Transcription;Transcriptional regulation of white adipocyte differentiation;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Signaling by NOTCH1;Signaling by NOTCH;IL-7 signaling;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;JAK STAT pathway and regulation;EPO signaling;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Signaling by TGF-beta Receptor Complex;VEGF;Signaling by TGF-beta family members;Diseases of signal transduction;NOTCH1 Intracellular Domain Regulates Transcription
(Consensus)
Recessive Scores
- pRec
- 0.203
Intolerance Scores
- loftool
- 0.425
- rvis_EVS
- -0.25
- rvis_percentile_EVS
- 35.42
Haploinsufficiency Scores
- pHI
- 0.835
- hipred
- Y
- hipred_score
- 0.749
- ghis
- 0.696
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cdk8
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype;
Gene ontology
- Biological process
- transcription initiation from RNA polymerase II promoter;protein phosphorylation;positive regulation of transcription by RNA polymerase II;regulation of cell cycle
- Cellular component
- nucleus;nucleoplasm;nucleolus;mediator complex;protein-containing complex
- Molecular function
- protein kinase activity;protein serine/threonine kinase activity;cyclin-dependent protein serine/threonine kinase activity;protein binding;ATP binding;RNA polymerase II CTD heptapeptide repeat kinase activity